Quote | Timber Pharmaceuticals Inc. (NYSE:TMBR)
Last: | $0.3426 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $0.3426 |
High: | $0 |
Low: | $0 |
Volume: | 26,307 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Timber Pharmaceuticals Inc. (NYSE:TMBR)
2023-11-29 17:40:57 ET More on Timber Pharmaceuticals Timber Pharmaceuticals files for Chapter 11 in wake of failed merger Timber Pharma slips ahead of shareholder vote on merger Financial information for Timber Pharmaceuticals For further details see: Ti...
WARREN, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Timber Pharmaceuticals, Inc. ("Timber" or the "Company") (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that...
Message Board Posts | Timber Pharmaceuticals Inc. (NYSE:TMBR)
Subject | By | Source | When |
---|---|---|---|
My bad, we actually closed at $3.14 up | subslover | investorshub | 02/27/2023 10:39:47 PM |
I guess the laws of physics don't apply | subslover | investorshub | 02/27/2023 10:15:13 PM |
55 .6 ,Million shares traded, OS 2.9 million. | WHIP THE HORSE | investorshub | 02/25/2023 7:25:30 PM |
$TMBR has 2.9 million OS but traded 52 | WHIP THE HORSE | investorshub | 02/24/2023 7:10:42 PM |
NEWS! ------ Timber Pharmaceuticals Receives European Orphan Drug | subslover | investorshub | 02/24/2023 2:07:49 PM |
News, Short Squeeze, Breakout and More Instantly...
Timber Pharmaceuticals Inc. Company Name:
TMBR Stock Symbol:
NYSE Market:
Timber Pharmaceuticals Inc. Website:
WARREN, N.J., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Timber Pharmaceuticals, Inc. ("Timber" or the "Company") (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that...
WARREN, NJ - ( NewMediaWire ) - November 28, 2023 - Timber Pharmaceuticals, Inc. (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, and its affiliated debtors and debtor-...
WARREN, NJ, Nov. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, and its affiliated d...